EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Continuous positive airway pressure versus high‐flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: A randomized controlled trial

Kazuma Nagata iD, Toshiki Yokoyama, Ryosuke Tsugitomi, Harunori Nakashima, Hiroshi Kuraishi, Shinichiro Ohshimo, Yoshihiro Mori, Masaaki Sakuraya, Ryogo Kagami, Motoaki Tanigawa, Kazunori Tobino, Tetsuro Kamo und 9 weitere

Respirology · 2024-01 · 29 (1) · 36-45

DOI: 10.1111/resp.14588 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Respirology, online erschienen am 30.08.2023. Verfasst von Kazuma Nagata und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan. Hauptthemen laut MEDLINE: Continuous Positive Airway Pressure, Respiratory Insufficiency. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Philips Japan Limited.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective The relative effectiveness of initial non‐invasive respiratory strategies for acute respiratory failure using continuous positive airway pressure (CPAP) or high‐flow nasal cannula (HFNC) is unclear.

Methods

We conducted a multicenter, open‐label, parallel‐group randomized controlled trial to compare the efficacy of CPAP and HFNC on reducing the risk of meeting the prespecified criteria for intubation and improving clinical outcomes of acute hypoxemic respiratory failure. The primary endpoint was the time taken to meet the prespecified criteria for intubation within 28 days.

Results

Eighty‐five patients were randomly assigned to the CPAP or HFNC group. Eleven (28.9%) in the CPAP group and twenty (42.6%) in the HFNC group met the criteria for intubation within 28 days. Compared with HFNC, CPAP reduced the risk of meeting the intubation criteria (hazard ratio [HR], 0.327; 95% CI, 0.148–0.724; p = 0.006). There were no significant between‐group differences in the intubation rates, in‐hospital and 28‐day mortality rates, ventilator‐free days, duration of the need for respiratory support, or duration of hospitalization for respiratory illness. Pulmonary oxygenation was significantly better in the CPAP group, with significantly lower pH and higher partial pressure of carbon dioxide, but there were no differences in the respiratory rate between groups. CPAP and HFNC were associated with few possibly causal adverse events.

Conclusion

CPAP is more effective than HFNC at reducing the risk of meeting the intubation criteria in patients with acute hypoxemic respiratory failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Continuous Positive Airway PressureRespiratory InsufficiencyHumansCannulaOxygen Inhalation TherapyOxygen

Stichwörter der Autor:innen

acute hypoxemic respiratory failurecontinuous positive airway pressurehigh-flow nasal cannula oxygen therapy

Substanzen

Oxygen

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
  • Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan.
  • Department of Pulmonary Medicine, Thoracic Center, St. Luke's International Hospital, Chuo City, Tokyo, Japan.
  • Department of Respiratory Medicine, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.
  • Department of Pulmonary Medicine, Nagano Red Cross Hospital, Nagano, Nagano, Japan.
  • Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Hiroshima, Japan.

ORCID-Profile: Kazuma Nagata, Toru Kadowaki, Yasuhiro Kondoh

Förderung

  • Philips Japan Limited

Zitieren

APA

Nagata, K., Yokoyama, T., Tsugitomi, R., Nakashima, H., Kuraishi, H., Ohshimo, S., Mori, Y., Sakuraya, M., Kagami, R., Tanigawa, M., Tobino, K., Kamo, T., Kadowaki, T., Koga, Y., Ogata, Y., Nishimura, N., Kondoh, Y., Taniuchi, S., Shintani, A., …, & JaNP-Hi Study Investigators (2024). Continuous positive airway pressure versus high‐flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: A randomized controlled trial. Respirology, 29(1), 36-45. https://doi.org/10.1111/resp.14588

Vancouver

Nagata K, Yokoyama T, Tsugitomi R, Nakashima H, Kuraishi H, Ohshimo S, et al. Continuous positive airway pressure versus high‐flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: A randomized controlled trial. Respirology. 2024;29(1):36-45. doi:10.1111/resp.14588

BibTeX
@article{Nagata2024,
  author = {Nagata, Kazuma and Yokoyama, Toshiki and Tsugitomi, Ryosuke and Nakashima, Harunori and Kuraishi, Hiroshi and Ohshimo, Shinichiro and Mori, Yoshihiro and Sakuraya, Masaaki and Kagami, Ryogo and Tanigawa, Motoaki and Tobino, Kazunori and Kamo, Tetsuro and Kadowaki, Toru and Koga, Yasutaka and Ogata, Yoshitaka and Nishimura, Naoki and Kondoh, Yasuhiro and Taniuchi, Satsuki and Shintani, Ayumi and Tomii, Keisuke and JaNP-Hi Study Investigators, JaNP-Hi Study Investigators},
  title = {Continuous positive airway pressure versus high‐flow nasal cannula oxygen therapy for acute hypoxemic respiratory failure: A randomized controlled trial},
  journal = {Respirology},
  year = {2024},
  volume = {29},
  number = {1},
  pages = {36--45},
  doi = {10.1111/resp.14588}
}
Kostenlos starten →